drugset / Trial / NCT03599635
Pec Infiltration With Liposomal Bupivacaine for Breast Surgery
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to compare pain control after breast surgery using either liposomal bupivacaine or bupivacaine when infiltrated during an ultrasound guided pectoralis 1 and 2 block. Both medications, liposomal bupivacaine and bupivacaine, are standard of care in these types of surgeries.
Timeline
- Start
- 2018-07-01
- Primary completion
- 2024-07-01
- Completion
- 2024-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 0.25 % | Other |
| Comparator | Bupivacaine | Other / unclassified | 20 ml | Other |
Indications
No indication recorded.